This has helped create a niche in the industry,which has spearheaded our rapid sales. have been created after extensive research, dedicated expert manpower, thorough and stringent clinical trials. Many of Troikaa’s products like Parenteral Emulsions (Propofol Etomidate injection), inhalation agents for anaesthesia (Isoflurane, Sevoflurane), Sublingual Tablets, etc. B) Strong Portfolio of Difficult to Manufacture Products: Agent-specific identification, medical symptoms, prevention & personal protective equipment, fire fighting, sampling & analytical methods, decontamination, spillage disposal, packaging & labeling information. It may affect our short-term profitability but it drives long-term growth.Our R&D innovations have helped steer us into global markets and made us a well-recognized company worldwide. Cyanide is believed to be cytotoxic with actions selective against cancerous cells, but results from animal studies were mostly negative. Sodium Cyanide Emergency Response Card: Information for First Responders.
This approach has helped us in creating path-breaking brands.Įach patentedbrand at Troikaa has stemmed from original innovations of which the lead time from concept to commercialization has been effectively maintained from 6 to 10 years. Our R&D Department is approved by the Department of Scientific & Industrial Research, Government of India and has an innovation-driven approach. A) Strong portfolio of Patented Innovations: The traditional antidote for cyanide poisoning involves formation of methemoglobin through the infusion of sodium nitrite.(90,91) This treatment has the.
0 kommentar(er)
